The Netherlands Cancer Institute Awarded Funding To Apply Molecular Imaging Technology To Prostate Cancer Surgery
/
DateOct 17 2017
In the joint research project, the Netherlands Cancer Institute, University of Twente and industry partners, Lightpoint Medical and Philips will evaluate a novel molecular imaging technology to image the prostate cancer biomarker Prostate Specific Membrane Antigen (PSMA) during surgery.